sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has submitted a disclosure form under Rule 8.3 of the Irish Takeover Panel Act. This disclosure concerns Mural Oncology plc. The form reveals that Vanguard holds 4.47% interest in Mural Oncology with 772,371 ordinary shares.
The form, dated 11 August 2025, indicates no involvement in any cash-settled or stock-settled derivatives in relation to the interest. The document also confirms that there were no agreements or arrangements concerning voting rights related to these securities.
No supplemental Form 8 was attached, signaling no additional disclosures were deemed necessary. This release forms part of regulatory requirements to inform stakeholders of significant shareholding positions in the context of a takeover or merger.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.